J. Gregory Mears

1.5k total citations
35 papers, 1.2k citations indexed

About

J. Gregory Mears is a scholar working on Molecular Biology, Genetics and Hematology. According to data from OpenAlex, J. Gregory Mears has authored 35 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 15 papers in Genetics and 12 papers in Hematology. Recurrent topics in J. Gregory Mears's work include Hemoglobinopathies and Related Disorders (10 papers), Folate and B Vitamins Research (7 papers) and Chronic Lymphocytic Leukemia Research (5 papers). J. Gregory Mears is often cited by papers focused on Hemoglobinopathies and Related Disorders (10 papers), Folate and B Vitamins Research (7 papers) and Chronic Lymphocytic Leukemia Research (5 papers). J. Gregory Mears collaborates with scholars based in United States, India and Ivory Coast. J. Gregory Mears's co-authors include Francesco Ramirez, Arthur Bank, R L Nagel, Dominique Labie, K Schaefer-Rego, C. Beldjord, J. Pagnier, D Leibowitz, Robyn J. Barst and Arthur D. Bloom and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

J. Gregory Mears

33 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Gregory Mears United States 16 647 458 304 141 136 35 1.2k
Jl. Michaux Belgium 22 742 1.1× 1.0k 2.2× 307 1.0× 207 1.5× 136 1.0× 68 1.6k
A Broustet France 20 353 0.5× 1.0k 2.2× 234 0.8× 291 2.1× 128 0.9× 108 1.5k
Tomas Ahlgren Sweden 17 436 0.7× 967 2.1× 353 1.2× 152 1.1× 128 0.9× 31 1.3k
C Dresch France 20 516 0.8× 665 1.5× 181 0.6× 120 0.9× 98 0.7× 72 1.1k
G. J. den Ottolander Netherlands 19 405 0.6× 556 1.2× 169 0.6× 122 0.9× 101 0.7× 58 1.0k
C. G. Geary United Kingdom 20 439 0.7× 856 1.9× 185 0.6× 149 1.1× 100 0.7× 62 1.2k
A. Berrebi Israel 11 286 0.4× 368 0.8× 136 0.4× 192 1.4× 48 0.4× 22 730
Ingunn Dybedal Norway 19 781 1.2× 1.5k 3.2× 429 1.4× 222 1.6× 185 1.4× 39 1.9k
G Broccia Italy 16 243 0.4× 695 1.5× 172 0.6× 212 1.5× 82 0.6× 39 931
Barbara Crescenzi Italy 18 235 0.4× 476 1.0× 344 1.1× 207 1.5× 134 1.0× 55 1.0k

Countries citing papers authored by J. Gregory Mears

Since Specialization
Citations

This map shows the geographic impact of J. Gregory Mears's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Gregory Mears with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Gregory Mears more than expected).

Fields of papers citing papers by J. Gregory Mears

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Gregory Mears. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Gregory Mears. The network helps show where J. Gregory Mears may publish in the future.

Co-authorship network of co-authors of J. Gregory Mears

This figure shows the co-authorship network connecting the top 25 collaborators of J. Gregory Mears. A scholar is included among the top collaborators of J. Gregory Mears based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Gregory Mears. J. Gregory Mears is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Mapara, Markus Y., Jai Radhakrishnan, Mathew S. Maurer, et al.. (2017). Final Analysis of the Phase 1a/b Study of Chimeric Fibril-Reactive Monoclonal Antibody 11-1F4 in Patients with Relapsed or Refractory AL Amyloidosis. Blood. 130. 509–509. 18 indexed citations
3.
Alobeid, Bachir, J. Gregory Mears, & Govind Bhagat. (2015). Follicular lymphoma (in situ) pattern in the bone marrow: does it indicate an early stage in disease evolution?. Clinical Case Reports. 3(6). 442–443. 2 indexed citations
5.
Leslie, Lori A., Benjamin Lebwohl, Alfred I. Neugut, et al.. (2012). Incidence of lymphoproliferative disorders in patients with celiac disease. American Journal of Hematology. 87(8). 754–759. 19 indexed citations
6.
Leslie, Lori A., Benjamin Lebwohl, Alfred I. Neugut, et al.. (2011). Increased Incidence of Non-Hodgkin Lymphoma Subtypes in Patients With Celiac Disease. Gastroenterology. 140(5). S–35. 1 indexed citations
7.
Schecter, Jordan M., J. Gregory Mears, Bachir Alobeid, & Paul J. Gaglio. (2007). Anti-erythropoietin antibody–mediated pure red cell aplasia in a living donor liver transplant recipient treated for hepatitis C virus. Liver Transplantation. 13(11). 1589–1592. 11 indexed citations
8.
Vakiani, Efsevia, Christian E. Keller, E Ho, et al.. (2006). The spectrum of myelodysplastic syndromes post-solid organ transplantation: A single institutional experience. Leukemia Research. 31(1). 59–65. 6 indexed citations
9.
Savage, David G., Charles S. Hesdorffer, Daniel F. Heitjan, et al.. (2003). Combined Fludarabine and Rituximab for Low Grade Lymphoma and Chronic Lymphocytic Leukemia. Leukemia & lymphoma. 44(3). 477–481. 24 indexed citations
10.
Savage, David G., J. Gregory Mears, Casilda Balmaceda, et al.. (2002). Leptomeningeal relapse of multiple myeloma following allogeneic stem cell transplantation. Leukemia Research. 26(7). 689–692. 8 indexed citations
11.
Beal, Kathryn & J. Gregory Mears. (2001). Short Report: Penile Lymphoma Following Local Injections for Erectile Dysfunction. Leukemia & lymphoma. 42(1-2). 247–249. 3 indexed citations
12.
Savage, David G., Gwen Nichols, Charles S. Hesdorffer, et al.. (2000). Combined fludarabine and rituximab for low grade lymphoproliferative disorders. Blood. 96. 1 indexed citations
13.
Chadburn, Amy, Jonathan M. Chen, Daphne T. Hsu, et al.. (1998). The morphologic and molecular genetic categories of posttransplantation lymphoproliferative disorders are clinically relevant. Cancer. 82(10). 1978–1987. 5 indexed citations
15.
Leibowitz, D, et al.. (1991). ABL oncogene expression during erythroleukemia cell differentiation. Leukemia Research. 15(1). 65–70. 3 indexed citations
16.
Pagnier, J., J. Gregory Mears, K Schaefer-Rego, et al.. (1984). Evidence for the multicentric origin of the sickle cell hemoglobin gene in Africa.. Proceedings of the National Academy of Sciences. 81(6). 1771–1773. 332 indexed citations
17.
Lachman, Herbert M. & J. Gregory Mears. (1983). DNase I hypersensitivity in the γ globin gene locus of K562 cells. Nucleic Acids Research. 11(17). 6065–6077. 18 indexed citations
18.
Mears, J. Gregory, et al.. (1981). Sickle gene. Its origin and diffusion from West Africa.. Journal of Clinical Investigation. 68(3). 606–610. 33 indexed citations
19.
Ramirez, Francesco, J. Gregory Mears, & Arthur Bank. (1980). The molecular basis of disorders of human hemoglobin synthesis. Molecular and Cellular Biochemistry. 31(1). 133–45. 5 indexed citations
20.
Mears, J. Gregory, et al.. (1979). Heterogeneity of DNA fragments associated with the sickle-globin gene.. Journal of Clinical Investigation. 64(3). 751–755. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026